<DOC>
	<DOCNO>NCT01222559</DOCNO>
	<brief_summary>This prospective , phase III , multicenter , open label , randomise clinical trial co.don chondrosphere® , three-dimensional autologous chondrocyte transplantation product ( ACT3D-CS ) compare procedure microfracture ( MF ) treatment cartilage defect knee joint . After screen visit patient book arthroscopy time randomise either ACT3D-CS co.don chondrosphere® ( Group A ) MF ( Group B ) , marrow-stimulating method base penetration subchondral bone plate bottom cartilage defect . At time arthroscopy Patients group B procedure MF ( treatment surgery ) patient group A cell harvest healthy cartilage . The cell cultivate 8-10 week vitro develope 3-dimensional spheroid , transplant open knee procedure ( treatment surgery ) defect . Patients subsequently follow rehabilitation program post-surgery visit . After 12-month-visit interim analysis perform 24-month-visit defined final assessment . Then patient follow-up assessment 60 month post-treatment-surgery .</brief_summary>
	<brief_title>Efficacy Safety Study co.Don Chondrosphere Treat Cartilage Defects</brief_title>
	<detailed_description>see</detailed_description>
	<criteria>1 . Male female patient , age : 18 50 year 2 . Defect : isolated ICRS grade III IV single defect chondral lesion femoral condyle 3 . Defect size : 1 &lt; 4 cm2 debridement healthy cartilage 6 mm depth.Assessment MRI screen per estimation arthroscopy prior randomization 4 . Nearly intact chondral structure surround defect well intact correspond joint area 5 . Informed consent sign date patient 6 . Patient understands strict rehabilitation protocol followup programme willing follow 7 . In case pain , patient agrees use paracetamol mono ( max 4 g/day ) combination preparation oral and/or topic NSAIDs trial discontinue use oral and/or topic NSAIDs and/or paracetamol combination preparation 1 week visit whereas use paracetamol monopreparation ( max 4 g/day ) allow . However , morning visit day , pain medication allow . Other pain medication allow surgical procedure may take period exceed 4 week surgery . 1 . Defects knees time 2 . Radiological sign osteoarthritis 3 . Osteochondritis dissecans ( OCD ) 4 . Any sign knee instability 5 . Valgus varus malalignment ( 5° mechanical axis ) 6 . Clinically relevant second cartilage lesion knee 7 . More 50 % resection meniscus affect knee incomplete meniscal rim 8 . Rheumatoid arthritis , parainfectious infectious arthritis , condition disease 9 . Pregnancy plan pregnancy ( MRI possible ) 10 . Obesity ( Body Mass Index &gt; 30 ) 11 . Uncontrolled diabetes mellitus 12 . Serious illness 13 . Poor general health judge physician 14 . Participation concurrent clinical trial previous trial within 3 month screen 15 . Previous treatment ACT affect knee 16 . Microfracture perform less 1 year screening affect knee 17 . Alcohol drug ( medication ) abuse 18 . Meniscal transplant affect knee 19 . Meniscal suture ( affected knee ) three month prior baseline 20 . Mosaicplasty ( Osteoarticular Transplant System , OATS ) affect knee 21 . Having receive hyaluronic acid intraarticular injection affect knee within last 3 month baseline 22 . Taking specific osteoarthritis drug chondroïtin sulfate , diacerein , nglucosamine , piascledine , capsaicin within 2 week baseline 23 . Corticosteroid treatment systemic intraarticular route within last month baseline intramuscular oral corticosteroïds within last 2 week baseline 24 . Chronic use anticoagulant 25 . Any concomitant painful disable disease spine , hip low limb would interfere evaluation afflict knee 26 . Any clinically significant symptomatic vascular neurological disorder low extremities 27 . Any evidence follow disease affect knee : septic arthritis , inflammatory joint disease , recurrent episode pseudogout , Paget 's disease bone , ochronosis , acromegaly , haemochromatosis , Wilson 's disease , primary osteochondromatosis , heritable disorder , collagen gene mutation 28 . Current diagnosis osteomyelitis , human immunodeficiency virus ( HIV1,2 ) and/or hepatitis C virus ( HCV ) infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Cartilage defect</keyword>
	<keyword>Knee joint</keyword>
	<keyword>Femoral Condyle</keyword>
</DOC>